Imricor Medical Systems, Inc. IMR.AX · Stock Open Imricor Medical Systems, Inc. in new tab
Analyst price targets
Recent rating changes, newest first
Imricor Medical Systems, Inc. Analysis (IMR.AX)
Is Imricor Medical Systems, Inc. a good investment? Imricor Medical Systems, Inc. (IMR.AX) is currently trading at 1.38 AUD. Market analysts have a consensus price target of 3.01 AUD. This suggests a potential upside from current levels.
Earnings Schedule: Imricor Medical Systems, Inc. is expected to release its next earnings report on Dec. 2, 2026. The market consensus estimate for Forward EPS is -0.10.
Investor FAQ
Does Imricor Medical Systems, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Imricor Medical Systems, Inc.?
Imricor Medical Systems, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Dec. 2, 2026. The company currently has a trailing EPS of -0.17.
Company Profile
Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States, Europe, and the Middle East. The company's products include Vision-MR Ablation Catheter 2.0, a MR-compatible cardiac ablation catheter; Vision-MR Diagnostic Catheter, a MR-compatible diagnostic catheter; NorthStar mapping system, a real-time, high-resolution soft tissue imaging of MRI to guide and visualize procedures with exceptional clarity; and Advantage-MR EP Recorder / Stimulator. The company through its Imricor Cardiovascular vertical provides integrated single session workflows for hospitals for MR imaging. It also offers Vision-MR Dispersive Electrode to minimize eddy currents induced on the device's conductive pads during MR scanning. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.
Community Discussion